Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study

被引:1276
|
作者
Knochenhauer, ES
Key, TJ
Kahsar-Miller, M
Waggoner, W
Boots, LR
Azziz, R
机构
[1] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Dept Occupat Hlth, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA
[4] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA
来源
关键词
D O I
10.1210/jc.83.9.3078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estimates of the prevalence of the polycystic ovary syndrome (PCOS) in the general population have ranged from 2-20%. The vast majority of these reports have studied White populations in Europe, used limited definitions of the disorder, and/or used bias populations, such as those seeking medical care. To estimate the prevalence of this disorder in the United States and address these limitations, we prospectively determined the prevalence of PCOS in a reproductive-aged population of 369 consecutive women (174 White and 195 Black; aged 18-45 yr), examined at the time of their preemployment physical. Body measures were obtained, and body hair was quantified by a modified Ferriman-Gallwey (F-G) method. All exams were initially performed by 2 trained nurses, and any subject with an F-G score above 3 was reexamined by a physician, the same for all patients. Of the 369 women, 277 (75.1%) also agreed to complete a questionnaire and have additional blood drawn. Subjects were studied regardless of current estrogen/progestin hormonal use (28.5%). PCOS was defined as 1) oligoovulation, 2) clinical hyperandrogenism (i.e. hirsutism) and/or hyperandrogenemia, and 3) exclusion of other related disorders, such as hyperprolactinemia, thyroid abnormalities, and nonclassic adrenal hyperplasia. Hirsutism was defined by a F-G score of 6 or more, and hyperandrogenemia was defined as a total or free testosterone, androstenedione, and/or dehydroepiandrosterone sulfate level above the 95th percentile of control values [i,e, all eumenorrheic women in the study, who had no hirsutism (F-G less than or equal to 5) or acne and were receiving no hormonal therapy; n = 98]. Considering all 369 women studied, White and Black women had similar mean ages (29.4 +/- 7.1 and 31.1 +/- 7.8 yr, respectively), although White women had a lesser body mass than Black women (24.9 +/- 6.1 vs. 29.2 +/- 8.1 kg/m(2), respectively; P < 0.001). Of these 7.6%, 4.6%, and 1.98 demonstrated a F-G score of 6 or more, 8 or 10, respectively, and there was no significant racial difference, with hirsutism prevalences of 8.0%, 2.8%, and 1.6% in Whites, and 7.1%, 6.1%, and 2.1% in Blacks, respectively. Of the 277 women consenting to a history and hormonal evaluation, 4.0% had PCOS as defined, 4.7% (6 of 129) of Whites and 3.4% (5 of 148) of Blacks. In conclusion, in our consecutive population of unselected women the prevalence of hirsutism varied from 2-8% depending on the chosen cut-off F-G score, with no significant difference between White and Black women. Using an F-G score of 6 or more as indicative of hirsutism, 3.4% of Blacks and 4.7% of Whites had PCOS as defined. These data suggest that PCOS may be one of most common reproductive endocrinological disorders of women.
引用
收藏
页码:3078 / 3082
页数:5
相关论文
共 50 条
  • [1] A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain
    Asunción, M
    Calvo, RM
    San Millán, JL
    Sancho, J
    Avila, S
    Escobar-Morreale, HF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07): : 2434 - 2438
  • [2] Prevalence of polycystic ovary syndrome in unselected women from southern China
    Chen, Xiaoli
    Yang, Dongzi
    Mo, Yaqin
    Li, Lin
    Chen, Yaxiao
    Huang, Yuhong
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 139 (01): : 59 - 64
  • [3] Prevalence and predictors of the metabolic syndrome in Saudi women with polycystic ovary syndrome: A prospective study
    Rouz, Abdulrahim A.
    Ardawi, Mohamed S.
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 168A - 168A
  • [4] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 2745 - 2749
  • [5] Women with Polycystic Ovary Syndrome: A Marginalized Population in the United States
    Sanchez, Ninive
    HEALTH & SOCIAL WORK, 2020, 45 (01) : 40 - 46
  • [6] Prevalence of metabolic syndrome in women with polycystic ovary syndrome
    Panidis, Dimitrios
    Macut, Djuro
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    Mikhailidis, Konstantinos
    Kandaraki, Eleni A.
    Tsourdi, Elena A.
    Tantanasis, Theoharis
    Mavromatidis, George
    Katsikis, Ilias
    CLINICAL ENDOCRINOLOGY, 2013, 78 (04) : 586 - 592
  • [7] Prevalence of metabolic syndrome in women with polycystic ovary syndrome
    Popovic, B.
    Macut, D.
    Bozic, I.
    Petakov, M.
    Ognjanovic, S.
    Isailovic, T.
    Damjanovic, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 426 - 427
  • [8] Prevalence of the metabolic syndrome in women with polycystic ovary syndrome
    Bregieiro Fernandes Costa, Laura Olinda
    Ribeiro Viana, Aline de Oliveira
    de Oliveira, Monica
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (01): : 10 - 17
  • [9] Randomize study: the prevalence of the metabolic syndrome in Greek women with polycystic ovary syndrome
    Kyrkou, G.
    Trakakis, E.
    Chrelias, C. H.
    Alexiou, E.
    Lykeridou, K.
    Mastorakos, G.
    HUMAN REPRODUCTION, 2013, 28 : 329 - 329
  • [10] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    Apridonidze, T
    Essah, PA
    Iuorno, MJ
    Nestler, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04): : 1929 - 1935